Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Current Evidence and Strategies to Address Sex Hormone-Associated Thrombotic and CV Risk
  The influences of sex hormone therapy – for contraception, treatment of heavy menstrual bleeding, hormone-replacement therapy, gender-affirming care therapy, etc. – on venous thrombotic and cardiovascular risk was explored in a Review Article published April 15 in NEJM.
• C-TRACT: Endovascular Therapy For Post-Thrombotic Syndrome Reduces Severity, Improves QOL
  Endovascular therapy added to standard care for post-thrombotic syndrome was associated with improved syndrome severity and quality of life (QOL) at six months compared with standard care alone in patients with moderate or severe post-thrombotic syndrome and iliac vein-obstruction...
• ACCEL Lite: Heart and Liver Health: Interconnectedness of CV and Hepatic Risk
  In this interview, Richard A. Chazal MD, MACC and Vishal N. Rao, MD, MPH examine the interconnectedness of cardiovascular (CV) and hepatic risk.
• ACC.26 Sports and Exercise Cardiology: Key Takeaways From the 75th Annual Scientific Sessions
  The Sports and Exercise Cardiology sessions at American College of Cardiology Annual Scientific Session 2026 (ACC.26) reinforced a central theme: exercise is both medicine and, in select contexts, a risk.
• MYO-AMY: Is Photon-Counting CT Comparable With CMR in LVH?
  When cardiac MR (CMR) is nondiagnostic, impractical or contraindicated, photon-counting computed tomography (PCCT) provides an assessment of ventricular geometry, function and myocardial fibrosis/PCCT-derived extracellular volume (ECV), that is comparable to CMR, while enabling angiography, in patients with left ventricular hypertrophy (LVH), according to results from the MYO-AMY cohort study published April 2 in JACC: Cardiovascular […]